BRIEF-Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmona
 

BRIEF-Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis
* Orphan drug designation in European Union for GLPG1690 inidiopathic pulmonary fibrosisSource text for Eikon: Further company coverage: (Gdynia Newsroom:)http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Oo:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Oo:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/Wp3wrww8Gt0